Prevention Better Than Cure? AC Immune's Parkinson’s Vaccine Approach
Executive Summary
With a broad pipeline focused on neurodegenerative disease, AC Immune is about to begin a Phase II program investigating an alpha-synuclein-targeted peptide vaccine with a diagnostic to stratify patients.